Neurotransmitter changes by interferon-alpha and therapeutic implications
by
Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A.
Department of Psychiatry and Psychotherapy,
Charite - University Medicine Berlin,
Campus Charite-Mitte (CCM), Berlin, Germany.
Pharmacopsychiatry. 2003 Dec;36 Suppl 3:203-6


ABSTRACT

Interferon alpha (IFN-alpha) is a cytokine that is widely used for the treatment of chronic viral infection or malignant disorders. During treatment with IFN-alpha, severe neuropsychiatric syndromes may occur such as depression with suicidal ideation, paranoid psychoses or confusional states. The neurobiological correlates of these side effects are widely unknown. Besides induction of other cytokines and hormonal changes, IFN-alpha has been shown to modulate the opioid, serotonin, dopamine and glutamate neurotransmitter system. Positive therapeutic effects of antidepressants such as selective serotonin-reuptake-inhibitors (SSRI) or of opioid receptor antagonists support the hypothesis that neurotransmitter changes play an important role in the development of IFN-alpha associated neuropsychiatric side effects. We review recent research about IFN-associated neurotransmitter changes in the central nervous system and discuss treatment strategies.
NSAIDs
Serotonin
Interferons
Depression
21st century
Cytokines and depression
Inflammation and depression
Depressive effect of cytokines
Cytokines, depression and antidepressants
An overactive immune system and depression
Cytokines and heart failure-induced anhedonia
Antidepressants, cytokines and mood disorders
The immune system, depression and antidepressants



Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family